Jefferies Group LLC Amylyx Pharmaceuticals, Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 2,791 shares of AMLX stock, worth $4,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,791
Previous 50,000
94.42%
Holding current value
$4,940
Previous $963,000
92.0%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
183Shares Held
50.3MCall Options Held
5.84MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA5.35MShares$9.47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$7.92 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.94MShares$5.21 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.47MShares$4.37 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$3.67 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $104M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...